Annals of Saudi Medicine
Publication of the King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Users Online: 17 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Home  About us   Issues     Search     Subscribe   Contact    Login 
 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 30  |  Issue : 1  |  Page : 25-32

Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus


1 National Center for Diabetes Endocrinology and Genetics, Amman, Jordan
2 Liver Department, Jordan University Hospital, Amman, Jordan
3 Department of Public Health, Community Medicine and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan

Correspondence Address:
Layla Judi
National Center for Diabetes Endocrinology and Genetics - Diabetology, Queen Rania St., PO Box 13165, Amman
Jordan
Login to access the Email id
DOI: 10.4103/0256-4947.59369

PMID: 20103955



Get Permissions

Background and Objectives : Since the extent of elevation of liver transaminases in type 2 diabetics in Jordan and most of the Middle East is unknown, we estimated the prevalence of elevated liver transaminase levels among patients with type 2 diabetes and determined associated risk factors. Methods : This study was performed on 1014 consecutive type 2 diabetic outpatients who attended the National Center for Diabetes, Endocrinology and Genetics in Amman, Jordan. The patients' age ranged between 26-85 years with a mean age of 56.8 (+9.8). Three- hundred and fifty three (54.5%) were males with a median age of 58 years (ranging between 26-82 years), and four hundred and sixty one (45.5%) were females with a median age of 57 years (ranging between 28-85 years). Body mass index, waist circumference, lipid profile, and hepatic transaminase levels were recorded. Ultraonography was performed in those with elevated alanine transaminase levels. Results : Overall, the prevalence of elevated alanine transaminase (ALT) level was 10.4% (n=105) with the gender-wise prevalence being 12.8% (n=71) in men and 7.4% (n=34) in women. The prevalence of elevated aspartate transaminase (AST) levels was 5.4% (n=56) with the gender-wise prevalence being 5.6% (n=31) in men and 5.4% (n=25) in women.. Only 4.5% (n=44) showed elevated levels of both ALT and AST. Male gender (OR=2.35, CI:1.5-3.8) and high waist circumference (OR=1.9, CI:1.2-3.2) were associated with increased risk of elevated ALT levels. Younger patients had a higher tendency to have elevated ALT compared to those over 65 years (OR=12.4 for patients aged 25-45years, and OR=5.8 for those who were 45-65 years old). Non-insulin use was associated with a high odds ratio for elevated ALT levels (OR=1.7, CI: 1.1-2.9). Conclusions : Elevated ALT and AST levels are found in 10.4% and 5.4% of our type 2 diabetic patients respectively. Male gender, younger age, higher waist circumference; as an indicator of central obesity, as well as non insulin use are independent predictors of elevated liver transaminase levels.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next Article
 Previous Article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed240    
    Printed12    
    Emailed0    
    PDF Downloaded135    
    Comments [Add]    

Recommend this journal